Home » Topics » BioWorld Science

BioWorld Science
RSS

Arginine analogues for shock

Sep. 6, 1996

E. Merck describes cardioactive agents

Sep. 6, 1996

Genentech claims CHF for heart failure and neurological disorders

Sep. 6, 1996

cGMP PDE inhibitors from Taisho

Sep. 6, 1996

Clinical trials to begin on laser for transmyocardial revascularization

Sep. 6, 1996

Generic nadolol approved

Sep. 6, 1996

CGS-28106 for hypertension and congestive heart failure

Sep. 6, 1996

Zambon selects a dopaminergic compound for evaluation in cardiovascular/renal disorders

Sep. 6, 1996

New angiotensin II antagonists from Kotobuki

Sep. 6, 1996

alpha1-Adrenoceptor blockers with advantages over prazosin

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...